Amanote Research
Register
Sign In
FRI0494 Secukinumab Provides Rapid and Sustained Pain Relief in Psoriatic Arthritis: 2-Year Results From the Future 2 Study
doi 10.1136/annrheumdis-2017-eular.5086
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
IB McInnes
PJ Mease
G Schett
B Kirkham
V Strand
N Williams
T Fox
L Pricop
S Jugl
KK Gandhi
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5‐year Results From the Phase 3 FUTURE 1 Study
ACR Open Rheumatology
THU0369 Secukinumab 150mg Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis With High Retention Rate: 3-Year Results From Phase Iii Trial, Measure 2
Progression of Fibromyalgia: Results From a 2-Year Observational Fibromyalgia and Chronic Pain Study in the US
Journal of Pain Research
Anesthesiology
Pain Medicine
Interleukin-17inhibition With Secukinumab Improves Sudomotor Dysfunction in Psoriatic Arthritis
International Journal of Pharmacy and Pharmaceutical Sciences
Pharmacology
Pharmaceutical Science
Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Certolizumab Pegol Is Associated With Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes From the Rapid-Psa Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Decreased Use of Glucocorticoids in Biological-Experienced Patients With Rheumatoid Arthritis Who Initiated Intravenous Abatacept: Results From the 2-Year ACTION Study
RMD Open
Rheumatology
Allergy
Immunology
Cardiovascular Risk Management in Rheumatoid and Psoriatic Arthritis: Online Survey Results From a National Cohort Study
BMC Rheumatology
Rheumatology
Matching-Adjusted Indirect Comparison: Secukinumab Versus Infliximab in Biologic-Naive Patients With Psoriatic Arthritis
Journal of Comparative Effectiveness Research
Health Policy
